Amicus Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Amicus Therapeutics Inc
TickerFOLD
CIK #0001178879
CUSIP03152W109
SectorLife Sciences - Pharmaceutical Preparations
Address6 Cedar Brook Drive, Cranbury, NJ 08512
Source [EDGAR]
CIK Filing 2011 - 2024
[0001178879] 10-K
[0001178879] 10-Q
[0001178879] 3
[0001178879] 4
[0001178879] 5
[0001178879] 8-K
[0001178879] D
[0001178879] SC 13D
[0001178879] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Morgan Stanley Amicus Therapeutics Inc [2023-02-08] 6.3
Perceptive Advisors LLC Amicus Therapeutics Inc [2022-03-02] 9.7
Perceptive Advisors LLC Amicus Therapeutics Inc [2022-02-22] 0.5
Avoro Capital Advisors LLC Amicus Therapeutics Inc [2022-02-11] 6.6
Wellington Management Group LLP Amicus Therapeutics Inc [2022-02-04] 0.56
JPMorgan Chase & Co Amicus Therapeutics Inc [2022-01-19] 5.5
Morgan Stanley Amicus Therapeutics Inc [2020-10-22] 5.7
Morgan Stanley Amicus Therapeutics Inc [2020-01-30] 5.1
Morgan Stanley Amicus Therapeutics Inc [2019-08-27] 5.6
Janus Henderson Group PLC Amicus Therapeutics Inc [2019-02-12] 5.8
Price T Rowe Associates Inc /MD/ Amicus Therapeutics Inc [2018-02-14] 5.4
venBio Select Advisor LLC Amicus Therapeutics Inc [2018-02-12] 5.3
Morgan Stanley Amicus Therapeutics Inc [2017-03-13] 5.0
Vanguard Group Inc Amicus Therapeutics Inc [2017-02-09] 5.85
Jennison Associates LLC Amicus Therapeutics Inc [2017-02-02] 6.5
Prudential Financial Inc Amicus Therapeutics Inc [2017-01-30] 6.9
BlackRock Inc Amicus Therapeutics Inc [2016-01-28] 7.1
FMR LLC Amicus Therapeutics Inc [2015-07-10] 0.0
Citadel Advisors LLC Amicus Therapeutics Inc [2015-04-22] 4.9
Sectoral Asset Management Inc Amicus Therapeutics Inc [2015-02-13] 5.1
Palo Alto Investors LLC Amicus Therapeutics Inc [2014-10-08] 2.49
Perceptive Advisors LLC Amicus Therapeutics Inc [2014-06-03] 12.96
Redmile Group LLC Amicus Therapeutics Inc [2013-11-29] 15.14
FMR LLC Amicus Therapeutics Inc [2012-04-10] 0.0
Form 3/4/5 Filer 2011 - 2024
Amicus Therapeutics Inc
Roberts EIRY
McGlynn Margaret G
Raab Michael
Sblendorio Glenn
Wheeler Craig A
Whitman Burke W
Kelly Michael Aaron
Bleil Lynn Dorsey
Campbell Bradley L
Crowley John F
Rosenberg Ellen
Quimi Daphne
Clark David Michael
Castelli Jeff
Prout Samantha
Essner Robert
Do Hung
Barth Jay
Love Ted W
Edelman Joseph
Perceptive Advisors LLC
Perceptive Life Sciences Master Fund Ltd
Baird William D III
Andrews Kurt J.
Hayden Donald J Jr
Green Jeremy
Redmile Group, LLC
Barer Sol J
Peist Kenneth
Valenzano Ken
Doshi Dipal
Gershkowitz Jayne
Dilone Enrique
Yu Julie
Baldry Mark
Kirk John
David Allsop
GSK PLC
Barrett M James
Topper James N
Macaluso Peter M
Winterbottom Joan
Lockhart David J
Boudes Pol F
Winkler Robert E
Gilmore Geoffrey
Perry Mark W
Kramlich C Richard
Barris Peter J
New Enterprise Associates 11 LP
Drant Ryan D
Sandell Scott D
NEA 11 GP LLC
NEA Partners 11 LP
Kolluri Krishna Kittu
Baskett Forest
Newhall Charles W III
Schaeffer Orlov S Nicole
Form 13F Holdings
Firm Period DFND Voting Shares
Perceptive Advisors LLC [2023-03-31] SOLE 27,662,917.0 27,662,917.0
Avoro Capital Advisors LLC [2023-03-31] SOLE 27,300,000.0 27,300,000.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 26,150,729.0
BlackRock Inc. [2023-03-31] SOLE 19,437,753.0 19,733,939.0
Redmile Group LLC [2023-03-31] SOLE 18,346,861.0 18,346,861.0
Morgan Stanley [2023-03-31] DFND 16,102,120.0 16,500,909.0
JPMorgan Chase & Co [2023-03-31] DFND 11,978,348.0 13,731,665.0
Janus Henderson Group PLC [2023-03-31] DFND 0.0 13,610,435.0
State Street Corp [2023-03-31] DFND 10,515,693.0 11,130,885.0
Palo Alto Investors LP [2023-03-31] SOLE 10,524,022.0 10,524,022.0
Pictet Asset Management Sa [2023-03-31] DFND 1.0 9,984,901.0
Wellington Management Group LLP [2023-03-31] DFND 0.0 7,515,041.0
Macquarie Group Ltd [2023-03-31] SOLE 7,078,016.0 7,171,035.0
Geode Capital Management LLC [2023-03-31] DFND 5,142,407.0 5,142,407.0
Fiera Capital Corp [2023-03-31] OTR 4,586,782.0 5,051,442.0
Artal Group S.A. [2023-03-31] DFND 3,526,407.0 3,526,407.0
Northern Trust Corp [2023-03-31] DFND 193,179.0 2,715,695.0
Bank of America Corp /DE/ [2023-03-31] DFND 137,226.0 2,500,066.0
Boxer Capital, LLC [2023-03-31] OTR 2,325,000.0 2,325,000.0
William Blair Investment Management LLC [2023-03-31] SOLE 1,665,947.0 2,281,092.0
Point72 Asset Management LP [2023-03-31] DFND 0.0 2,249,128.0
FMR LLC [2023-03-31] DFND 2,204,432.0 2,207,238.0
Balyasny Asset Management LP [2023-03-31] SOLE 2,117,050.0 2,117,050.0
Novo Holdings A/S [2023-03-31] SOLE 2,095,900.0 2,095,900.0
Charles Schwab Investment Management Inc [2023-03-31] SOLE 2,066,158.0 2,066,158.0
Millennium Management LLC [2023-03-31] SOLE 1,938,583.0 1,938,583.0
Goldman Sachs Group Inc [2023-03-31] DFND 1,831,814.0 1,898,424.0
Healthcare of Ontario Pension Plan Trust Fund [2023-03-31] SOLE 1,819,500.0 1,819,500.0
D. E. Shaw & Co., Inc. [2023-03-31] DFND 1,632,797.0 1,651,597.0
Victory Capital Management Inc [2023-03-31] SOLE 1,617,168.0 1,617,168.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com